The US Food and Drug Administration’s Office of Prescription Drug Promotion has hit Pfizer subsidiary Hospira with an untitled letter over the company's "misleading" YouTube video on its sedative ...
Add Yahoo as a preferred source to see more of our stories on Google. Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years before ...
Hosted on MSN
Lilly’s Zepbound seen beating Pfizer injection
Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a market analyst who compared the drug to a rival injection from Pfizer. The comment comes as drugmakers race to meet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results